Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0242379 (lung cancer)
 71,905 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

As bleomycin has up to now proved effective when used alone, the main thrust of current clinical investigations predominantly concerns its use in combination with other drugs. This has occurred along three broad patterns: 1) combination with vinca alkaloids which has been mainly in testicular carcinoma; 2) as part of multidrug regimens where bleomycin added for its lack of myelosuppression. This has occurred in the malignant lymphomas, lung cancer, and head and neck cancer; 3) in combination with radiotherapy which has taken place mostly in head and neck cervix cancer. To date, the combination of velban and bleomycin has had a major impact in improving the ability to induce complete remissions in advanced testicular carcinoma. Other drugs such as cis-platinum diaminedichloride and actinomycin D have been added and no definitive combination has been established. In the lymphomas the addition of bleomycin to the MOPP or CVP regimen has given higher complete response rates, but long-term survival data are still awaited.
 ...
PMID:A review of the bleomycin experience in the United States. 8 99

The 49 patients with squamous cell type of cervical, lung, esophagus and head and neck cancers were treated with a sequential combination of bleomycin (BLM) and mitomycin C (MMC) as follows; 5 mg of BLM daily for 5 or 7 days followed by a single injection of 10 mg of MMC on day 6 or day 8. After one week of rest period, this course was repeated two to five times depending on the response or adverse effects. For cervical cancer, 17 patients out of 18 (94%) responded with complete remission (CR) in 13 (72%) and partial remission (PR) in 4 (22%). For lung cancer, four patients out of five responded. In two of the responders, metastatic tumors disappeared completely, but primary tumors decrease to about 10% in volume. For esophagal cancer, one patient out of 3 had CR after combining the BLM and MMC treatment with radiotherapy. For head and neck cancer, these were some differences in the response rates between two hospitals. In one hospital, 12 patients out of 22 (53%) responded, with CR in 4 (18%), whereas in the other hospital, 10 patients out of 11 (94%) responded, including eight with CR (72%). Regarding the toxicity, the overall incidence was very low, although lung complications were frequent. These results are promising with hopeful prospects for the control of advanced squamous cancers with metastasis.
 ...
PMID:A sequential combination of bleomycin and mitomycin C in the treatment of advanced squamous cancers. 8 1

The cytogenetic control of 17 mouse tumor cell strains from of the collection of the bank of the Centre for Oncology Research of the AMS USSR was made: 4 leukemias (L-5178Y, L-1210, L-1210 resistant to 6-mercaptopurine, P-388), 2 sarcomas (S-180, S-298), 8 carcinomas (Ehrlich ascitic carcinoma, carcinoma 755,6-mercaptopurine resistant carcinoma 755, lung cancer LC-67, cervical cancer CC-2, cervical cancer CC-5, stomach cancer GC-5), 2 melanomas (B16, S91) and 1 plasmocytoma (MOPC 21). A comparison of their cytogenetic features allowed a conclusion to be drawn on the absence of any contamination among 14 strains of this collection. Carcinoma 755, sarcoma 298 and leukemia L-5178Y need some further examination for such inference to be valid.
 ...
PMID:[Cytogenetic characteristics of transplantable mouse tumors]. 29 90

Serum lysozyme has been demonstrated to be an indicator for macrophage activity in the tumor-bearing host. Therefore, we investigated lysozyme levels in the sera of 336 untreated tumor patients (121 malignant melanoma, 61 lung cancers, 70 cervical cancers, 49 breast cancers and 35 benign breast tumors, and 36 healthy controls). Patients with malignant melanoma and lung cancer had significantly higher lysozyme levels than the healthy controls. Within the clinical stages in melanoma, there was a decrease of lysozyme in stages II and III in comparison to stage I, but still above that of the control values. Patients with benign breast tumors had normal levels, whereas in breast cancer patients of stages I and II there was a significant reduction in the lysozyme levels. In stages III and IV no differences to the control group could be detected. In patients with cervical cancer (FIGO II and III) serum lysozyme levels were found to be within the normal range. From this study it can not be concluded that serum lysozyme reflects the immunological reactivity of the tumor bearer. Nevertheless, the reduced levels in stages I and II of breast cancer might point to an immunological defect.
 ...
PMID:Serum lysozyme levels in patients with solid tumors. 45 Mar 87

Based on the epidemiologic literature, the problem of mass cancer screening projects is discussed. In the case of breast cancer the evidence for a reduction of mortality in the age group over 50 seems conclusive, whereas the specific role of mammography is still controversial. At present, no routine mammographic screening should be undertaken in women under 50 years of age. There is presumptive evidence that routine proctosigmoidoscopy for early diagnosis of cancer of the large bowel reduces mortality. However, this method seems of doubtful practical value for financial and psychological reasons. There is reason to believe that improvement in colorectal survival rates may be expected with widespread use of the "Hemoccult" test. Routine screening for cervical cancer should be continued, although the epidemiological evidence of its value is only circumstantial. In the case of lung cancer, there is not much hope that secondary prevention will improve mortality rates. Earlier detection of prostatic cancer by means of digital examination may eventually improve mortality rates, but at present the evidence is lacking.
 ...
PMID:[Problems of early detection of neoplasms from an epidemiological point of view]. 68 99

The accuracy of death certificate diagnoses of cancer in the fixed population of about 100,000 samples in Hiroshima and Nagasaki was determined for the period 1961 approximately 1970 by comparison with autopsy findings. In general, when the death certificate listed cancer as a cause of death it was found at autopsy in a high proportion of cases. However, cancer was not always reported on death certificates, indicating that cancer occurs more frequently than recorded by official mortality statistics. Older persons, persons who die at home, and persons with certain cancers are more likely not to have cancer named on their death certificates. It is estimated that in the 10,749 deaths occurring at home or in hospital, there were 32% more deaths due to cancer than certified on death certificates (3,095 vs. 2,345) and for persons aged 70 or more dying at home it is estimated there were 55% more stomach cancer (269 estimated vs. 174 listed) and 244% more lung cancer (141 estimated vs. 41 listed) than were certified on death certificates. The death certificate is not a good source of information for cancer of the cervix because many cases of this disease reported on death certificates as cancer of the uterus. This practice needs to be taken into account in the use of mortality data for cervical cancer in Japan.
 ...
PMID:Accuracy of diagnosis of cancer among autopsy cases: JNIH--ABCC population for Hiroshima and Nagasaki. 101 79

The records of the two main referral centres for the western and central Arctic were reviewed for Eskimo patients with cancer diagnosed between 1949 and 1974 inclusive. To these were added the records for the past 6 years of patients from the eastern Arctic, giving the toatal of 180 histologically proved cases of malignant disease. Athe data were analysed for prevalence, relative frequency, geographic distribution and changes with time of the various neoplasms. Salivary gland and renal neoplasms have in recent years been displaced by cancer of the lung and uterine cervix as the most common malignant tumours in Canadian Eskimos. The prevalence of lung cancer in Eskimo women, particularly of the central Artic, is striking. Cancer of the nasopharynx kept the same relative position during early and late years of the survey period. Breast cancer is still uncommon in Eskimos. Lactation rather than gestation history appeared to be an important protective factor. Cases of cervical cancer outnumbered those of breast cancer by 18 to 4, in sharp contrast to the relative proportions of these tumours in all Canadian women.
 ...
PMID:The changing pattern of neoplastic disease in Canadian Eskimos. 113 84

The recent surge of interest in the mechanisms of action of biomodulators, also known as biological response modifiers, offers a new avenue of approach in the treatment of cancer. The in vitro antitumor activities of these agents, such as interferons, when combined with chemo- or radiotherapy, have generated enthusiasm among clinicians for developing clinical trials. In recent years many antineoplastic agents have been investigated as neoadjuvant or adjuvant therapy for patients with cervical cancer in an attempt to improve local control and to decrease incidence of metastasis. Normal tissue tolerance limits the potential combinations of standard cytotoxic chemotherapeutic agents with radiation. Interferon used as a radiomodulator has been studied mainly for the treatment of lung cancer with promising results. In this paper we report the rationale of combining interferon and radiation for the treatment of patients with cervical cancer.
 ...
PMID:Rationale of combining radiation and interferon for the treatment of cervical cancer. 128 35

1. Rates for lung cancer in Canadian Inuit are high and increasing for both men and women; in fact they are the highest reported rates for lung cancer among any Inuit population. 2. Cervical cancer in Canadian Inuit are high but rates appear to be stable, unlike the rapidly increasing trend reported in both Alaska and Greenland. 3. Rates for traditional Inuit cancers such as those of the nasopharynx and salivary gland do not appear to be declining in Canadian Inuit. 4. Rates for colorectal cancer in Canadian Inuit are similar to those expected for the Canadian population as a whole and do not appear to be increasing. 5. Finally, cancers traditionally reported to be rare in Inuit are still rare in the Canadian Inuit population; these include breast, prostate, bladder, and endometrial cancer. Cancer is a disease which can be controlled through prevention, early detection or treatment. The following future directions arising from this work reflect this paradigm. First, the Inuit cancer registry developed for this analysis will be used as a base for further research into environmental and genetic factors influencing cancer rates in the Inuit. Second, given that at least 40% of cancers in Canadian Inuit are cancers of the lung and cervix, health promotion programs should be developed to encourage tobacco-free environments to halt the epidemic of lung cancer, and also to make available Pap smear programs for early detection of cervical cancer. Third, health care services and programs, including diagnosis and treatment, should be culturally accessible to the Inuit population (6).(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Cancer patterns in the Inuit population of Canada 1970-1984. 136 87

A cohort of 3637 female and 168 male hair-dressers in Finland was followed up for cancer through the Finnish Cancer Registry in 1970-1987. Compared with the total population, the women had a significantly elevated risk (standardized incidence ratio 1.7) during the first third of the observation period, but not thereafter. For the total follow-up period, the relative risks were highest for nonmelanoma skin cancer (2.0), lung cancer (1.7), ovarian cancer (1.6), cervical cancer (1.5), and cancer of the pancreas (1.5); only the risk of ovarian cancer was statistically significant. A decrease in relative risk with time was observed for many primary sites, e.g., pancreas, cervix uteri, central nervous system, and thyroid. The opposite was true for lung and skin: An increased risk was found only in 1982-1987. The excess was most prominent in the oldest age groups with the longest time span since the first employment as a hairdresser. Among men, too, the general cancer risk was highest (1.6) during the first third of the observation period. An excess of cancers of the lung and the pancreas was observed. The small numbers, however, did not allow any further conclusions. The changes in the cancer risk pattern over time may be associated with changes in working conditions in hairdressing salons.
 ...
PMID:Changing cancer risk pattern among Finnish hairdressers. 139 13


1 2 3 4 5 6 7 8 9 10 Next >>